In 2009, BOTOX gained competition when Dysport (abobotulinumtoxinA) was developed, approved by the FDA, and made available to the general public. Both drugs are used to relax the facial muscles that cause wrinkles and frown lines. Some practices lean toward BOTOX to address forehead lines while considering Dysport for crow’s feet. There has been much debate as to which drug is superior, as both have their advantages. Distinct differences can be discussed during your consultation.